Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
47.7M
-
Shares change
-
+945K
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
+$20.1M
-
Put/Call ratio
-
72.96
-
Number of buys
-
87
-
Number of sells
-
-79
-
Price
-
$22.84
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q1 2025
211 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q1 2025.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.7M shares
of 48M outstanding shares and own 99.22% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (8.71M shares), BlackRock, Inc. (5.47M shares), Invesco Ltd. (3.55M shares), VANGUARD GROUP INC (2.8M shares), FRED ALGER MANAGEMENT, LLC (1.53M shares), STATE STREET CORP (1.43M shares), T. Rowe Price Investment Management, Inc. (1.35M shares), AMERIPRISE FINANCIAL INC (970K shares), Rockefeller Capital Management L.P. (964K shares), and PALISADE CAPITAL MANAGEMENT, LP (947K shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.